Biora Therapeutics. has filed a patent for ingestible devices capable of delivering therapeutic agents through a unique system involving a storage reservoir and burst disk mechanism. The technology allows controlled release of substances within the body for medical purposes. GlobalData’s report on Biora Therapeutics gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Biora Therapeutics Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Biora Therapeutics, Ingestible drug delivery devices was a key innovation area identified from patents. Biora Therapeutics's grant share as of January 2024 was 24%. Grant share is based on the ratio of number of grants to total number of patents.

Ingestible device for delivering therapeutic agents

Source: United States Patent and Trademark Office (USPTO). Credit: Biora Therapeutics Inc

The patent application (Publication Number: US20230363663A1) describes an ingestible device designed to deliver a dispensable substance through a series of innovative mechanisms. The device includes a housing containing the substance, at least one nozzle, a force generator to exert pressure on the substance, and a burst disk or bioabsorbable plug that controls the release of the substance. The force generator generates pressure to activate the burst disk or plug, allowing the substance to be expelled through the nozzle in a controlled manner. The design also includes features such as multiple nozzles for balanced reaction forces, a storage reservoir formed by a slidable piston, and the use of bioabsorbable materials for controlled release.

Furthermore, the ingestible device is designed to deliver the substance with precision and efficiency. The patent application details variations of the device, including different configurations of the burst disk or bioabsorbable plug, the positioning of the nozzles, and the pressure range generated by the force generator. The device is intended to be ingested and deliver the substance in a jet form that can penetrate mucosal or epithelial layers in the small intestines. With features like equally spaced nozzles and a pressure range of 100-360 psi, the device aims to provide a reliable and effective method for delivering substances internally. The patent application showcases a novel approach to ingestible devices that could have significant implications in the field of medical treatment and drug delivery.

To know more about GlobalData’s detailed insights on Biora Therapeutics, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies